EP3630724
Setnar indólín-afleiður sem hindrar fyrir eftirmyndun beinbrunasóttarveiru
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
18.5.2018EP published:
28.4.2021EP application number:
18729051.5
EP translation filed:
2.6.2021Grant published:
15.6.2021EPO information:
European Patent Register
Max expiry date:
17.5.2038Expiry date:
17.5.2024
Title:
SUBSTITUTED INDOLINE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS
Timeline
Today
18.5.2018EP application
28.4.2021EP Publication
2.6.2021Translation submitted
15.6.2021Registration published
17.5.2024Expires
Owner
Name:
Janssen Pharmaceuticals, Inc.Address:
1125 Trenton-Harbourton Road, Titusville, NJ 08560, US
Name:
Katholieke Universiteit LeuvenAddress:
Waaistraat 6, Bus 5105, 3000 Leuven, BE
Inventor
Name:
BONFANTI, Jean-FrançoisAddress:
92787 Issy-les-Moulineaux Cedex 9, FR
Name:
KESTELEYN, Bart, Rudolf, RomanieAddress:
2340 Beerse, BE
Name:
BARDIOT, Dorothée, Alice, Marie-EveAddress:
3001 Leuven (Heverlee), BE
Name:
MARCHAND, Arnaud, Didier, MAddress:
3001 Leuven (Heverlee), BE
Name:
COESEMANS, ErwinAddress:
2340 Beerse, BE
Name:
DE BOECK, Benoît, Christian, Albert, GhislainAddress:
2340 Beerse, BE
Name:
RABOISSON, Pierre, Jean-Marie, BernardAddress:
2340 Beerse, BE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
17172247Date:
22.5.2017Country:
EP
Classification
Categories:
C07D 209/30, C07D 209/32, C07D 209/42, C07D 471/04, C07D 513/04, A61K 31/437, A61K 31/404, A61K 31/407, A61P 31/14
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 22.6.2021
Expires: 17.5.2022
Payer: Árnason Faktor ehf.
Number: 5
Paid: 5.4.2022
Expires: 17.5.2023
Payer: Árnason Faktor ehf.
Number: 6
Paid: 12.4.2023
Expires: 17.5.2024
Payer: Árnason Faktor ehf.